Literature DB >> 24442144

Reply to Is progesterone a neutral or protective factor for breast cancer?

Cathrin Brisken1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24442144     DOI： 10.1038/nrc3518-c2

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  4 in total

1.  Comparative study of Her-2, p53, Ki-67 expression and clinicopathological characteristics of breast cancer in a cohort of northern China female patients.

Authors:  Li Ding; Zijin Zhang; Yan Xu; Yongqiang Zhang
Journal:  Bioengineered       Date:  2017-01-11       Impact factor: 3.269

2.  A human breast atlas integrating single-cell proteomics and transcriptomics.

Authors:  G Kenneth Gray; Carman Man-Chung Li; Jennifer M Rosenbluth; Laura M Selfors; Nomeda Girnius; Jia-Ren Lin; Ron C J Schackmann; Walter L Goh; Kaitlin Moore; Hana K Shapiro; Shaolin Mei; Kurt D'Andrea; Katherine L Nathanson; Peter K Sorger; Sandro Santagata; Aviv Regev; Judy E Garber; Deborah A Dillon; Joan S Brugge
Journal:  Dev Cell       Date:  2022-05-25       Impact factor: 13.417

3.  Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling.

Authors:  Hari Singhal; Marianne E Greene; Allison L Zarnke; Muriel Laine; Rose Al Abosy; Ya-Fang Chang; Anna G Dembo; Kelly Schoenfelt; Raga Vadhi; Xintao Qiu; Prakash Rao; Bindu Santhamma; Hareesh B Nair; Klaus J Nickisch; Henry W Long; Lev Becker; Myles Brown; Geoffrey L Greene
Journal:  Oncotarget       Date:  2017-09-28

4.  Associations of Estrogen Receptor, Progesterone Receptor, Human Epidemic Growth Factor Receptor-2 and Ki-67 with Ultrasound Signs and Prognosis of Breast Cancer Patients.

Authors:  Xingjuan Zhao; Xuan Yang; Lei Fu; Keda Yu
Journal:  Cancer Manag Res       Date:  2021-06-09       Impact factor: 3.989
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.